Literature DB >> 21680139

High-flex posterior cruciate-retaining vs posterior cruciate-substituting designs in simultaneous bilateral total knee arthroplasty: a prospective, randomized study.

Kazuyoshi Yagishita1, Takeshi Muneta, Young-Jin Ju, Toshiyuki Morito, Junya Yamazaki, Ichiro Sekiya.   

Abstract

The superiority between the posterior cruciate-retaining and the posterior cruciate-substituting designs still remains controversial. We performed a prospective, randomized control study for evaluation of the superiority of these designs. This study investigated 58 knees in 29 patients with simultaneous bilateral total knee arthroplasty, in which the high-flex CR design was randomly implanted in one knee and the high-flex PS design was implanted in the other knee. The follow-up duration averaged 5.0 years, with a minimum duration of 3 years. Postoperatively, Knee Score and pain points in Knee Score resulted in no significant differences between the 2 designs. However, postoperative arc of range of motion, patient satisfaction, and posterior knee pain at passive flexion in the PS design were significantly superior to that of the CR design. Copyright Â
© 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21680139     DOI: 10.1016/j.arth.2011.05.008

Source DB:  PubMed          Journal:  J Arthroplasty        ISSN: 0883-5403            Impact factor:   4.757


  13 in total

Review 1.  Posterior cruciate ligament-retaining and posterior-stabilized total knee arthroplasty: differences in surgical technique.

Authors:  Roberto D'Anchise; Mauro Andreata; Cristiana Balbino; Nicola Manta
Journal:  Joints       Date:  2013-06-12

2.  Patellar tilt and thickness do not influence postoperative flexion in a high-flex design total knee arthroplasty.

Authors:  Aad Alfons Maria Dhollander; David Bassens; Jan Victor; Peter Verdonk
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2012-10-19       Impact factor: 4.342

3.  Active Flexion in Weight Bearing Better Correlates with Functional Outcomes of Total Knee Arthroplasty than Passive Flexion.

Authors:  Young Dong Song; Nimash Jain; Yeon Gwi Kang; Tae Yune Kim; Tae Kyun Kim
Journal:  Knee Surg Relat Res       Date:  2016-06-01

Review 4.  Common controversies in total knee replacement surgery: Current evidence.

Authors:  Vasileios S Nikolaou; Dimitrios Chytas; George C Babis
Journal:  World J Orthop       Date:  2014-09-18

5.  Cruciate Retaining compared with Posterior Stabilised Nexgen total knee arthroplasty: results at 10 years in a matched cohort.

Authors:  Aiw Mayne; H P Harshavardhan; L R Johnston; W Wang; A Jariwala
Journal:  Ann R Coll Surg Engl       Date:  2017-06-27       Impact factor: 1.891

6.  High-flexion prosthesis improves function of TKA in Asian patients without decreasing early survivorship.

Authors:  Bum-Sik Lee; Jong-Won Chung; Jong-Min Kim; Kyung-Ah Kim; Seong-Il Bin
Journal:  Clin Orthop Relat Res       Date:  2013-05       Impact factor: 4.176

7.  Return to Play and Performance in Golfers After Total Knee Arthroplasty: Does Component Type Matter?

Authors:  Joseph S Tramer; Lindsay M Maier; Elizabeth A Klag; Ayooluwa S Ayoola; Michael A Charters; W Trevor North
Journal:  Sports Health       Date:  2021-06-04       Impact factor: 4.355

Review 8.  Similar outcome after retention or sacrifice of the posterior cruciate ligament in total knee arthroplasty.

Authors:  Wiebe C Verra; Lennard G H van den Boom; Wilco C H Jacobs; Jan W Schoones; Ate B Wymenga; Rob G H H Nelissen
Journal:  Acta Orthop       Date:  2014-10-17       Impact factor: 3.717

9.  High-Flexion Total Knee Arthroplasty Using NexGen LPS-Flex System: Minimum 5-year Follow-up Results.

Authors:  Seung Joon Rhee; Sung Min Hong; Jeung Tak Suh
Journal:  Knee Surg Relat Res       Date:  2015-09-01

10.  Posterior Cruciate Ligament Retention versus Posterior Stabilization for Total Knee Arthroplasty: A Meta-Analysis.

Authors:  Chao Jiang; Zhenlei Liu; Ying Wang; Yanyan Bian; Bin Feng; Xisheng Weng
Journal:  PLoS One       Date:  2016-01-29       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.